Physician
Pediatric Associates of Lewiston P.A.
Pediatric Associates of Lewiston P.A. was paid $13.27M by Medicaid between Jan 2018 and Dec 2024, across 82 billing codes. Its largest line is 99214, doctor's office visit, returning patient (more involved) — 46% of everything it billed.
33Billing provider infoPEDIATRIC ASSOCIATES OF LEWISTON P.A.
LEWISTON, ME 04240
LEWISTON, ME 04240
33aNPI1184709495assigned 10/26/2006
33bProvider typePediatrics Physician
28Total paid$13.27M
24GClaims249,495
24DCodes billed82
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Pediatrics Physician providers in Maine
Rank by total paid#2 of 22
Median peer was paid$76K
This provider vs. median174×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 32,866 | $1.81M | |
| 2019 | 39,339 | $1.98M | |
| 2020 | 32,484 | $1.69M | |
| 2021 | 34,510 | $1.78M | |
| 2022 | 33,833 | $1.88M | |
| 2023 | 34,910 | $1.95M | |
| 2024incomplete | 41,553 | $2.17M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 46% | 60,212 | 57,453 | $6.10M |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 19% | 34,007 | 32,552 | $2.46M |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | 5.2% | 7,118 | 7,008 | $696K |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | 4.9% | 6,673 | 6,575 | $653K |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | 4.7% | 29,539 | 29,087 | $621K |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | 4.0% | 5,749 | 5,456 | $537K |
| 99215 | Doctor's office visit, returning patient (complex)Prolong outpt/office vis | 3.2% | 3,279 | 3,126 | $421K |
| T1013 | Sign language or oral interpretive services, per 15 minutes | 2.6% | 8,171 | 7,715 | $349K |
| 90472 | Immunization administration, each additional vaccine (list separately) | 2.4% | 16,205 | 15,981 | $318K |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | 1.9% | 2,296 | 2,266 | $247K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | 1.3% | 3,980 | 3,767 | $169K |
| 93303 | Transthoracic echocardiography for congenital cardiac anomalies, follow-up or limited study | <1% | 682 | 665 | $86K |
70 more codes
| 92587 | <1% | 4,230 | $78K | |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | <1% | 388 | $59K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 5,006 | $55K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 4,455 | $49K |
| 99205 | Prolong outpt/office vis | <1% | 379 | $40K |
| 87637 | Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV | <1% | 403 | $38K |
| 36416 | <1% | 9,901 | $30K | |
| 93320 | <1% | 672 | $30K | |
| 99238 | Hospital discharge day management, 30 minutes or less | <1% | 430 | $30K |
| 99174 | <1% | 2,267 | $24K | |
| 93000 | <1% | 1,475 | $20K | |
| 99460 | <1% | 200 | $18K | |
| 94760 | <1% | 9,846 | $18K | |
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | <1% | 2,033 | $16K |
| 93325 | <1% | 673 | $14K | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 1,320 | $11K |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | <1% | 355 | $11K |
| 96127 | <1% | 2,720 | $8K | |
| 99000 | <1% | 2,101 | $8K | |
| 90474 | <1% | 629 | $7K | |
| 99173 | <1% | 4,311 | $5K | |
| 83655 | <1% | 375 | $4K | |
| 87807 | <1% | 390 | $4K | |
| 90832 | Psychotherapy session, about 30 minutes | <1% | 79 | $4K |
| 99188 | <1% | 157 | $3K | |
| 90473 | <1% | 113 | $2K | |
| 99204 | Doctor's office visit, new patient (more involved) | <1% | 26 | $2K |
| 99429 | <1% | 137 | $2K | |
| 90791 | Psychiatric diagnostic evaluation | <1% | 21 | $2K |
| 99443 | <1% | 55 | $2K | |
| D1206 | Topical application of fluoride varnish | <1% | 142 | $2K |
| 90834 | Psychotherapy session, about 45 minutes | <1% | 21 | $1K |
| 0071A | <1% | 35 | $1K | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 100 | $1K |
| 96160 | <1% | 1,475 | $1K | |
| 90480 | <1% | 30 | $1K | |
| D0145 | Oral evaluation for a patient under three years of age | <1% | 92 | $1K |
| 93224 | <1% | 14 | $1K | |
| 99442 | <1% | 45 | $1K | |
| 99464 | <1% | 12 | $837.12 | |
| 0072A | <1% | 21 | $776.58 | |
| S8100 | Holding chamber or spacer for use with an inhaler or nebulizer; without mask | <1% | 158 | $723.07 |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 91 | $678.86 |
| 99462 | <1% | 13 | $534.95 | |
| 80061 | Lipid panel | <1% | 26 | $356.20 |
| 85018 | <1% | 133 | $281.06 | |
| S8101 | Holding chamber or spacer for use with an inhaler or nebulizer; with mask | <1% | 88 | $246.00 |
| 81003 | <1% | 80 | $168.08 | |
| 99070 | <1% | 12 | $120.00 | |
| 3085F | 0% | 944 | $0.00 | |
| 90672 | 0% | 103 | $0.00 | |
| 90670 | 0% | 1,493 | $0.00 | |
| 90633 | 0% | 385 | $0.00 | |
| 90671 | 0% | 131 | $0.00 | |
| 91321 | 0% | 13 | $0.00 | |
| 90734 | 0% | 104 | $0.00 | |
| 90715 | 0% | 13 | $0.00 | |
| 90700 | 0% | 15 | $0.00 | |
| 90707 | 0% | 12 | $0.00 | |
| 90686 | 0% | 6,984 | $0.00 | |
| A4616 | Tubing (oxygen), per foot | 0% | 383 | $0.00 |
| 90723 | 0% | 839 | $0.00 | |
| 90680 | 0% | 443 | $0.00 | |
| J7615 | Levalbuterol, inhalation solution, compounded product, administered through dme, unit dose, 0.5 mg | 0% | 864 | $0.00 |
| 90677 | 0% | 299 | $0.00 | |
| 90647 | 0% | 451 | $0.00 | |
| 90651 | 0% | 151 | $0.00 | |
| 90697 | 0% | 123 | $0.00 | |
| 91307 | 0% | 61 | $0.00 | |
| 90716 | 0% | 38 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialHETT, DAN (PRACTICE ADMINISTRATOR)